Ancistrocladine
From DrugPedia: A Wikipedia for Drug discovery
Ancistrocladine
| |
Systematic (IUPAC) name | |
(1S,3S)-5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol | |
Identifiers | |
CAS number | ? |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C25H29NO4 |
Mol. mass | 407.50206 |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
[edit] Description
RN refers to (-)-stereoisomer; structure given in first source Alkaloid, ancistrocladine, isolated from Ancistrocladus heyneanus wall.
[edit] General Properties
*Molecular Weight
407.50206
*Molecular Formula
C25H29NO4
*IUPAC NAME
(1S,3S)-5-(4,5-dimethoxy-2-methylnaphthalen-1-yl)-8-methoxy-1,3-dimethyl-1,2,3,4-tetrahydroisoquinolin-6-ol
*Canonical Smiles
CC1CC2=C(C(=CC(=C2C(N1)C)OC)O)C3=C4C=CC=C(C4=C(C=C3C)OC)OC
*Isomeric Smiles
C[C@H]1CC2=C(C(=CC(=C2[C@@H](N1)C)OC)O)C3=C4C=CC=C(C4=C(C=C3C)OC)OC
*XLogP
5.3
*Topological Polar Surface Area
60